ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

Group Chairmen Propose Adding Four Trials For High Priority Status

July 6, 1990

Henschke and Supporters Call For Urgent Action Based On Results Of NLST

May 13, 2011

DCT Board Ok’s Grants Program For AIDS Malignancies, Contracts

October 23, 1992

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

New CCP Lineup remains Unclear; 11 Bases OK’d

April 5, 1991

Congress Ignores construction Fund Reprogramming

February 18, 1977